Libby's H*O*P*E*

*Helping*Ovarian Cancer Survivors*Persevere Through*Education

Menu

Skip to content
  • Home
  • About
  • Mission
  • Warning Signs & Symptoms
  • Ovarian Cancer Overview
  • Prevention, Early Detection/Screening & Causes
  • Genetics
  • Types of Ovarian Cancer
  • Diagnosis & Staging
  • Treatment Overview
  • Surgery
  • Chemotherapy
  • Radiology & Radiation Therapy
  • Hormonal (Anti-Estrogen) Therapy
  • Biological (Immunotherapy & Vaccine) Therapy
  • Gene Therapy
  • Alternative & Complementary Therapy
  • Clinical Development
  • Clinical Trials
  • Coping
  • Survivorship
  • Ovarian Cancer Resources
  • Contact

Contact






Share this:

  • Facebook
  • Twitter
  • Google
  • Pinterest
  • LinkedIn
  • Tumblr
  • Reddit
  • Pocket
  • Print
  • Email

Like this:

Like Loading...
"Once you choose hope, anything is possible." -- Christopher Reeve

Categories

Twitter Updates

My Tweets

RSS Google Ovarian Cancer News

  • First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery - Ovarian Cancer News Today October 16, 2017
  • Mum was told by doctors for six months she had anxiety - but it was ovarian cancer and it went on to kill her - Belfast Telegraph October 16, 2017
  • Study: Don't Delay Platinum Re-Challenge in Ovarian Cancer - MedPage Today October 11, 2017
  • FDA Approval Sought for Maintenance Rucaparib in Ovarian Cancer - OncLive October 10, 2017
  • New Maintenance Therapy for Ovarian Cancer Seeks FDA Approval - Curetoday.com October 12, 2017
  • Can Treatment at a Large Cancer Center Mitigate Racial Disparities ... - Curetoday.com October 12, 2017
  • Higher lymphocyte infiltration predicts increased ovarian cancer ... - International Federation of Gynecology and Obstetrics October 16, 2017
  • New Hope For Ovarian Cancer - HuffPost September 26, 2017
  • Village View: Party with a Purpose for cancer research - Main Line October 16, 2017
  • Vancouver Woman Sharing Signs of Ovarian Cancer With Others ... - U.S. News & World Report October 1, 2017

Top Posts

  • About
    About
  • 2009 ASCO Annual Meeting Abstracts Now Available Online
    2009 ASCO Annual Meeting Abstracts Now Available Online
  • Genetics
    Genetics
  • Chemotherapy
    Chemotherapy
  • Ovarian Cancer Tumors Can Grow For Ten Years Or More Before Being Detected By Today's Blood Tests
    Ovarian Cancer Tumors Can Grow For Ten Years Or More Before Being Detected By Today's Blood Tests
  • World Ovarian Cancer Day: One Voice for Every Woman
    World Ovarian Cancer Day: One Voice for Every Woman
  • Alternative & Complementary Therapy
    Alternative & Complementary Therapy
  • PARP Inhibitor Olaparib Has Activity in High-Grade Serous Ovarian Cancer Without Inherited BRCA1 or BRCA2 Gene Mutations
    PARP Inhibitor Olaparib Has Activity in High-Grade Serous Ovarian Cancer Without Inherited BRCA1 or BRCA2 Gene Mutations
  • Role For Gemcitabine As Second-line Chemotherapy in Recurrent Clear Cell Ovarian Cancer
    Role For Gemcitabine As Second-line Chemotherapy in Recurrent Clear Cell Ovarian Cancer
  • Exelixis Reports Promising Interim Data From Ovarian Cancer Patients Treated With XL184
    Exelixis Reports Promising Interim Data From Ovarian Cancer Patients Treated With XL184

Archives

  • May 2015
  • September 2014
  • August 2014
  • May 2014
  • March 2014
  • August 2013
  • May 2013
  • February 2013
  • January 2013
  • July 2012
  • June 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008

Blog Stats

  • 474,313 Visitors
cancer blog

Enter your email address to subscribe to Libby's H*O*P*E* & receive notifications of new posts by email.

Join 2,115 other followers

 Subscribe in a reader

Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, or (ii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.

Donate To Ovarian Cancer Research

OCRF is the largest U.S. private funding agency supporting ovarian cancer research. It is a not-for-profit, 501(c)(3) organization. Click on the OCRF logo above to make a donation.

Strategic Partners

Podcasts

Join Us In the Fight Against Ovarian Cancer

RSS New Ovarian Cancer Clinical Trials (Past 14 Days)

  • Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma October 5, 2017
  • Intraperitoneal Aerosolisation of Albumin-stabilized Paclitaxel Nanoparticles for Recurrent GI and Ovarian Cancer October 6, 2017
  • Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042 October 12, 2017
  • PSMA PET and MRI in Gynecological Cancers October 4, 2017
  • Fractional CO2 Laser Therapy in Treating Vaginal Atrophy in Patients With Breast or Gynecologic Cancer October 11, 2017
  • Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer October 4, 2017
  • Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer October 3, 2017

RSS New Adult Solid Tumor Clinical Trials (Past 14 Days)

  • AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations October 16, 2017
  • A Phase II Study of the CDK4/6 Inhibitor Abemaciclib in Patients With Solid Tumors Harboring Genetic Alterations in Genes Encoding D-type Cyclins or Amplification of CDK4 or CDK6 October 16, 2017
  • First-in-Human Study of MS201408-0005A as Single Agent and in Combinations October 11, 2017
  • ATRi Transition Rollover Study October 13, 2017
  • Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor October 3, 2017
  • Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies October 4, 2017
  • Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042 October 12, 2017
  • Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence October 6, 2017
  • Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer October 9, 2017

RSS Medical Studies

  • Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines.
  • Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.
  • The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
  • New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines.
  • Cytotoxicity and cellular uptake of different sized gold nanoparticles in ovarian cancer cells.
  • Folate-decorated and NIR-activated nanoparticles based on platinum(IV) prodrugs for targeted therapy of ovarian cancer.
  • Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women.
  • Ruptured external iliac artery pseudoaneurysm following surgery for ovarian cancer: A case report and literature review.

Recent Comments

Paul Cacciatore on About
Building a Team for… on About
Kathleen on About
Paul Cacciatore on About
Liz on About
Paul Cacciatore on Dana Farber Webchat: The Lates…
Judith Marengere on Dana Farber Webchat: The Lates…
Paul Cacciatore on Dana Farber Webchat: The Lates…
Franca Pichini on Dana Farber Webchat: The Lates…
painspeaks on SU2C Announces the Formation o…
marcy westerling on SU2C Announces the Formation o…
anne on Dana-Farber Oncologists Differ…
Personalized Medicin… on 2011 ASCO: Matching Targeted T…
YoTrip Presents: Sep… on U.S. President Barack Obama Pr…
Paul Cacciatore on U.S. President Barack Obama Pr…

Blogroll

  • Site Meter Site Meter

Cancer Organizations

  • American Cancer Society
  • National Cancer Institute

Everyday Heroes

  • Are You There Cancer? It's Me, Jennie.
  • Bald Heads Are Sexy
  • Butterfly Ballet
  • Cancer Queen
  • Carrie's Journey
  • Chris Bledy
  • Diary of a Cancer Patient
  • I Want To Breathe
  • Janine's News
  • Journey Through Ovarian Cancer
  • Kristi & Brian: Living! With Cancer
  • Laurey Bikes
  • Life Cycle
  • livingly dying
  • Marcheline Bertrand Remembered
  • Meghan's Message
  • Monday Hearts For Madalene
  • My Journey With Teal
  • Nobody Has Ovarian Cancer
  • Out Shine Ovarian Cancer
  • OVACOM
  • Ovarian Cancer News
  • Ovarian Cancer?? pass the wine … now!
  • Scrambled Eggs, Surviving Ovarian Cancer
  • Shannon Miller Lifestyle
  • Still Smiling
  • Strong As Steele
  • Tenaciously Teal
  • The Carcinista
  • What? Me Worry?
  • Will There Be Cows In Heaven?
  • Women of Teal

Inspirational Cancer Advocates

  • Bald Is Beautiful
  • Bicycling For Ovarian Cancer (Craig Broeder)
  • Christine Druther
  • Fran Drescher
  • Imerman Angels
  • Jenn Sommermann: Training For a Cure
  • Jim Valvano
  • Laurey Masterton
  • Maddie Kullen
  • Mothers With Cancer
  • Randy Pausch
  • Sean Swarner
  • Standup2cancer
  • The Rock Band N.E.D.

Ovarian Cancer News Archive

  • Ovarian Cancer News Archive

Ovarian Cancer Organizations

  • National Breast & Ovarian Cancer Connection
  • National Ovarian Cancer Coalition
  • Ovarian Cancer National Alliance
  • Ovarian Cancer Research Fund
  • Ovations For the Cure

U.S. Treatment Centers

  • National Comprehensive Cancer Network Member Institutions
  • NCI-Designated Cancer Centers

Video Archive

  • Ovarian Cancer Video Library
Copyright 2008 - 2016 Paul Cacciatore, Libby's H*O*P*E*(TM), *Helping *Ovarian Cancer Survivors *Persevere Through *Education(TM), all rights reserved.
Paul Cacciatore

Create Your Badge
Site Meter
Blog at WordPress.com.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: